TAILIEUCHUNG - Pulmonary/Respiratory Therapy Secrets 3E

Dyspnea is the subjective sensation of uncomfortable or difficult breathing. Most patients report dyspnea as "shortness of breath." Patients report dyspnea when their breathing is excessive for the activity that they are doing. The sensation of dyspnea is produced by stimulation of both central and peripheral receptors that monitor respiratory muscle activity, hypoxia, hypercapnia, acid-base status, airway irritation, and changes in the pressure volume characteristics of the lung (., j receptors in lung fibrosis or emphysema). There are many systems and conditions that contribute to dyspnea, including cardiopulmonary, hematologic, psychosocial, and environmental (., high altitude) factors; body habitus (., obesity); fever; and level of exercise. Any situation. | Parsons Heffner Pulmonary Respiratory Therapy Secrets 3E PDF version By m_natee Content I. BEDSIDE EVALUATION 1 TAKING THE PULMONARY HISTORY 2 PHYSICAL EXAMINATION 3 SMOKING CESSATION 4 PULMONARY REHABILITATION 5 PULMONARY DISABILITY EVALUATION 6 PREOPERATIVE ASSESSMENT OF THE PULMONARY PATIENT 7 POSTOPERATIVE PULMONARY CARE II. DIAGNOSTIC IMAGING 8 CHEST RADIOGRAPHS 9 COMPUTED TOMOGRAPHY SCANS AND ULTRASOUND 10 PULMONARY ANGIOGRAPHY AND MAGNETIC RESONANCE IMAGING OF THE CHEST III. LABORATORY EVALUATION 11 ARTERIAL BLOOD GASES 12 PULSE OXIMETRY 13 PULMONARY FUNCTION TESTING 14 CLINICAL EXERCISE TESTING IV. PROCEDURES 15 THORACENTESIS AND PERCUTANEOUS PLEURAL BIOPSY 16 BRONCHOSCOPY 17 INTERVENTIONAL PULMONOLOGY 18 CHEST TUBES 19 FLOW-DIRECTED PULMONARY ARTERY CATHETERS 20 MEDIASTINOSCOPY 21 THORACOSCOPY V. AIRWAY DISEASE 22 ASTHMA 23 CHRONIC OBSTRUCTIVE LUNG DISEASE 24 CYSTIC FIBROSIS VI. INFECTIOUS DISEASE 25 COMMUNITY-ACQUIRED PNEUMONIA 26 NOSOCOMIAL PNEUMONIA 27 ASPIRATION SYNDROMES 28 FUNGAL PNEUMONIA 29 PARASITIC INFECTIONS 30 VIRAL PNEUMONIA 31 PNEUMONIA PREVENTION 32 EMPYEMA AND LUNG ABSCESS 33 TUBERCULOSIS 34 ATYPICAL MYCOBACTERIA VII. PULMONARY COMPLICATIONS OF AIDS 35 INFECTIOUS PULMONARY COMPLICATIONS OF HIV INFECTION 36 NONINFECTIOUS PULMONARY COMPLICATIONS OF HIV INFECTION VIII. PULMONARY VASCULAR DISEASES 37 THROMBOEMBOLIC DISEASE 38 NONTHROMBOTIC PULMONARY EMBOLI 39 PULMONARY HYPERTENSION IX. INTERSTITIAL LUNG DISEASES 40 GENERAL APPROACHES TO INTERSTITIAL LUNG DISEASE 41 SARCOIDOSIS 42 IDIOPATHIC PULMONARY FIBROSIS 43 COLLAGEN VASCULAR DISEASE 44 BRONCHIOLITIS BRONCHIOLITIS OBLITERANS AND SMALL AIRWAY DISEASE X. VASCULITIS AND IMMUNOLOGIC DISEASES 45 SMALL VESSEL VASCULITIS WEGENER S GRANULOMATOSIS MICROSCOPIC POLYANGIITIS AND CHURG-STRAUSS SYNDROME 46 DIFFUSE ALVEOLAR HEMORRHAGE XL VENTILATORY DISORDERS 47 SLEEP APNEA SYNDROMES 48 ALVEOLAR HYPOVENTILATION XII. OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES 49 SILICOSIS COAL WORKERS PNEUMOCONIOSIS AND

• Môi trường
• PULMONARY HISTORY
• PHYSICAL EXAMINATION
• SMOKING CESSATION
• DIAGNOSTIC IMAGING
• LABORATORY EVALUATION
• PROCEDURES
• AIRWAY DISEASE
• BMC Pulmonary Medicine
• Systemic artery to pulmonary artery fistulas
• Pulmonary arterial hypertension
• Nonreversible arterial pulmonary hypertension
• Above mentioned risk factors
• Fast facts
• Chronic obstructive pulmonary disease
• Pathology and pathogenesis
• Etiology and natural history
• Clinical features
• Lung function tests
• Bacterial community
• Stable COPD
• Airflow limitation
• Granulomatous Polyangiitis
• Case report
• Multisystem autoimmune disease
• Anti neutrophil cytoplasmic antibodies
• trình bày báo cáo
• tài liệu báo cáo khoa học
• báo cáo y học
• kiến thức y học
• nghiên cứu y học
• Executive Summary
• Automobile Pricing
• Practices and Impacts
• Relationship Between
• Mileage and Crash Costs
• Pricing Alternatives
• Symptom control
• Surprisingly little
• Cross sectional study
• Lung function
• Noninvasive ventilation
• Acute hypercapnic respiratory failure
• Randomized controlled trial
• Frequent exacerbations
• Brazilian Agribusiness
• Forestry and Life
• Cycle Assessment
• Wildlife Forestry
• Fire Ignition
• Trends in Durango